Back
Helen Of Troy 10K Form
Sell
46
HELE
Helen Of Troy
Last Price:
68.11
Seasonality Move:
11.05%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-01-08 | 10Q | HELE/Helen Of Troy Quarterly |
2023-10-04 | 10Q | HELE/Helen Of Troy Quarterly |
2023-07-10 | 10Q | HELE/Helen Of Troy Quarterly |
2023-01-06 | 10Q | HELE/Helen Of Troy Quarterly |
2022-10-06 | 10Q | HELE/Helen Of Troy Quarterly |
2022-07-08 | 10Q | HELE/Helen Of Troy Quarterly |
Receive HELE News And Ratings
See the #1 stock for the next 7 days that we like better than HELE
HELE Financial Statistics
Sales & Book Value
Annual Sales: | $2.01B |
---|---|
Cash Flow: | $39.71M |
Price / Cash Flow: | 8.19 |
Annual Sales: | $68.71 |
Price / Book: | 0.95 |
Profitability
EPS (TTM): | 5.97000 |
---|---|
Net Income (TTM): | $141.85M |
Gross Margin: | $948.66M |
Return on Equity: | 9.04% |
Return on Assets: | 4.93% |
Helen Of Troy Earnings Forecast
Key Helen Of Troy Financial Ratios
- The Gross Profit Margin over the past 40 years for HELE is 47.31%.
- The Selling, General & Administrative Expenses for HELE have been equal to 33.38% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 31.48% of Operating Income.
- The Net Earning history of HELE is 8.41% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 27 years.
Helen Of Troy Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Household Durables |
Sector: | Consumer Discretionary |
Current Symbol: | HELE |
CUSIP: | G4388N |
Website: | helenoftroy.com |
Debt
Debt-to-Equity Ratio: | 0.46 |
---|---|
Current Ratio: | 1.77 |
Quick Ratio: | 0.79 |
Price-to-Earnings
Trailing P/E Ratio: | 9.31 |
---|---|
Forward P/E Ratio: | 8.35 |
HELE Technical Analysis vs Fundamental Analysis
Sell
46
Helen Of Troy (HELE)
is a Sell
Is Helen Of Troy a Buy or a Sell?
-
Helen Of Troy stock is rated a Sell
The current Helen Of Troy [HELE] share price is $66.80. The Score for HELE is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.